Zack Bloom Associate Corporate Zack advises life sciences and technology companies on a broad range of corporate and transactional matters. Before joining Fenwick, Zack was an associate at a prominent international law firm in Boston.
Media Coverage Rob Freedman Discusses Capital Markets Surge for Obesity Treatments with Law360 October 1, 2024
Experience Fenwick Represents BioAge Labs in $238M Upsized Initial Public Offering and Concurrent Private Placement October 1, 2024
Experience Fenwick Represents Science Exchange in Acquisition by Waud Capital Partners September 30, 2024